Reconsider Beta-Blockers for Patients with Diabetes?
This study demonstrated that in patients with type 2 diabetes mellitus, use of β-blockers was associated with an increased risk for cardiovascular events and severe hypoglycemia. Details here.
Artificial Sweeteners and their Contradictory Outcomes
A new meta-analysis finds that routine intake of artificial sweeteners is linked to weight gain and metabolic dysfunction. Wait, what?
COPD--Impact of Undertreated Symptoms
A new study reports the impact on work productivity and lifestyle of undertreated COPD in the US, Europe, and China.
Updated 2017 GOLD Recommendations for COPD
Important revisions to the GOLD recommendations include a new definition of COPD and refined diagnostic categories.
High Baseline CRP Predicts Mortality in COPD, Study Says
There are no optimal markers to predict mortality in COPD but results of a new study support further investigation of CRP.
COPD Morning Symptoms: Why Not a Treatment Goal?
A recent literature review found that up to 90% of COPD patients experience ADL-limiting morning symptoms.
Among Never-smokers, Black Women at Highest Risk for COPD
Results of a new study suggest that racial inequalities in COPD, especially in women, may be shaped by socioeconomic factors.
Prognostic Power of the BCSS in Severe COPD
The Breathlessness, Cough and Sputum Scale, used to evaluate COPD treatment efficacy, may help predict exacerbations in severe disease.
Symptom Clusters and Biomarkers in COPD
The CASCADE study found the biomarker of inflammation CRP associated with higher COPD symptom burden.
Long-Term Oxygen in COPD No Better Than None
A new study sought to clarify conflicting findings on the impact of supplemental oxygen on exacerbations, hospitalization, and quality of life.